Magellan BioScience Group, Inc.

We are a cGMP contract manufacturer of finished drug products for clinical trials Phases I and II; we specialize in the production of solids and semi-solids as well as oral liquids. With a staff of experts dedicated to QUALITY discovery and development - we are here to assist your product development.

Activity:

- Contract Manufacturing
- Contract Research
- Research & Development
- Other Industry Services

Product / Technology type(s) covered:

- Generics
- FP (finished products)
- NCE (new chemical entities)
- OTC (over the counter drugs)
- Pharmaceuticals / Therapeutics
- Phyto
- Nutritionals / Vitamins
- Prescription drugs (Rx)

Therapeutic targets:

- AIDS
- Cancer
- Cardiovascular
- Central nervous system
- Gastrointestinal
- Infectious Diseases
- Oncology
- Women's Health

Markets Covered

a. HeadQuarter: United States of America

b. Continent(s) active: North America , Central/South America , Europe , Asia

c. Countries active: North America, Central America, Europe, Asia

Corporate data:

Number of Employees: 8

Turnover:

Amount:	Year:	Currency:
0	2005	US Dollar

Year founded: 1997